Monday, June 27, 2022
HomeSportsSouth Korea authorizes use of Novavax COVID-19 vaccine

South Korea authorizes use of Novavax COVID-19 vaccine


Novavax says COVID vaccine triggers immune response to Omicron variant

FILE PHOTO: Vials labeled “VACCINE Coronavirus COVID-19” and a syringe are seen in entrance of a displayed Novavax brand on this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration

SEOUL — South Korea has licensed the usage of Novavax Inc’s COVID-19 vaccine, the meals and drug security ministry stated on Wednesday.

South Korean vaccine developer SK Bioscience Co Ltd stated it is going to produce the Novavax vaccine.

The 2-dose, protein-based vaccine has secured authorizations from European Union regulators and the World Well being Group.

It has been licensed in India, Indonesia and the Philippines, the place Novavax’s companion, Serum Institute of India, will provide it.

Novavax is awaiting approval in Japan, the place its vaccine could be manufactured and distributed by Takeda Pharmaceutical.

South Korea has already licensed vaccines made by AstraZeneca Inc, Moderna Inc, Pfizer and Johnson & Johnson’s Janssen.

RELATED STORY
S.Korea to start producing Novavax COVID-19 vaccine as early as June

Subscribe to our each day e-newsletter

Learn Subsequent

Do not miss out on the newest information and knowledge.

Subscribe to INQUIRER PLUS to get entry to The Philippine Every day Inquirer & different 70+ titles, share as much as 5 devices, take heed to the information, obtain as early as 4am & share articles on social media. Name 896 6000.

For suggestions, complaints, or inquiries, contact us.



RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments